Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | DUT | P33316 | 3/20 | 0.36 |
| ▸ | CTSK | P43235 | 3/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.30 |
| ▸ | MPI | P34949 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11800596 | 0.95 | TK1 (0.44) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL8588054 | 0.95 | TK1 (0.44) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL27863708 | 0.95 | TK1 (0.44) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL24587233 | 0.87 | TK1 (0.48) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL6516985 | 0.87 | TK1 (0.48) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL10438660 | 0.81 | TK1 (0.44) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL2485765 | 0.81 | TK1 (0.37) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL10772460 | 0.80 | TK1 (0.54) | TK1KIF11DUTCTSKCYP2C9 | |
| SCHEMBL14059571 | 0.79 | TK1 (0.40) | TK1CTSK | |
| SCHEMBL29150776 | 0.78 | TK1 (0.48) | TK1KIF11DUTCTSKCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025055972-A1 | METHOD FOR SYNTHESIZING SUCRALOSE BY ENZYMATIC CATALYSIS | 安徽金禾实业股份有限公司 | 2025-03-20 | — | — | WO | disclosed |
| CN-117210518-A | Method for synthesizing sucralose by enzymatic catalysis | 安徽金禾实业股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| US-20040137582-A1 | Methods for manufacturing polysaccharide derivatives | RENSSELAER POLYTECHNIC INSTITUTE | 2004-07-15 | — | — | US | disclosed |
| WO-2004024774-A2 | METHODS FOR MANUFACTURING POLYSACCHARIDE DERIVATIVES | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2004-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040137582-A1 | Methods for manufacturing polysaccharide derivatives | SI, MGAM, IDUA | TK1 2594/4885KIF11 3403/4885DUT 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.